Our new San Diego location is currently under development, and will include more than 63,000 square feet of mixed-use space optimized for both laboratory operations and research and development. The office will consolidate the company’s two San Diego locations under one roof in Torrey Pines, the center of the city’s life science cluster.
|Service Desk Technician II (Monday-Friday: 8:30am-4:30pm PST)||Information Technology||101167||San Diego||California||United States||Towne Centre Ct., San Diego, California, United States||Technology||About the Job The Service Desk Technician II will be responsible for supporting the daily operations of IT requests of the business by resolving issues with both computer hardware and software. The technician will respond to user inquiries, asses...|
|Asset Manager||Facilities||100866||San Diego||California||United States||Towne Centre Ct., San Diego, California, United States||Operations||About the Job The Asset Manager is responsible for maintaining laboratory systems and for the coordination of Calibrations, PM’s and repairs to ensure the efficient delivery of patient test results. Responsibilities for this role include planned ...|
|Senior Scientist, Early Research & Development||ctDNA-Research and Early Development||100911||San Diego||California||United States||Towne Centre Ct., San Diego, California, United States||R&D||About the Job The Senior Scientist is part of the Research and Early Development group within FMI’s R&D function. This position explores new technologies and biomarker modalities to address unmet needs in the oncology field using liquid biops...|
|Scientist II, Product Development||Assay Development||101003||San Diego||California||United States||Towne Centre Ct., San Diego, California, United States||R&D||About the Job The Scientist II, Product Development supports the late-stage development and optimization of next generation sequencing (NGS) based assays in our clinical labs. Leveraging strong working knowledge of molecular biology, the incumben...|
|Manager, Environmental Health and Safety||Facilities||100917||San Diego||California||United States||Towne Centre Ct., San Diego, California, United States||Operations||About the Job The Manager, Environmental Health and Safety (EHS) oversees environmental, health, and safety related policies, procedures, and programs of FMI for a designated workspace. The position’s scope spans both laboratory and office EHS. T...|
|Associate Director, Franchise Development||Franchise Development||100482||San Diego. Cambridge||California. Massachusetts||United States||Towne Centre Ct., San Diego, California, United States. Second Street, Cambridge, Massachusetts, United States||R&D||About the Job The Associate Director, Franchise Development helps to lead the strategy and implementation of a designated product or portion of the clinical product portfolio. The position is responsible for directing the strategy, ideation, rele...|
The new laboratory space will help to expand testing capacity of the company’s recently FDA-approved FoundationOne Liquid CDx liquid biopsy test. Additionally, with Foundation Medicine’s acquisition of Lexent Bio* in June, the new space will allow for increased research and development of low-pass whole genome sequencing and DNA methylation analysis. The site hosts the following teams - Laboratory Operations, Facilities, Technology, TOCR, Research and Development (Early Research and Assay Development), Medical, and Legal teams. Client Services and other teams will be there as well soon.
“This state-of-the-art facility provides the opportunity to further expand our R&D and laboratory operations and supports our focus on advancing personalized medicine for patients,” said Foundation Medicine’s Chief Scientific Officer Priti Hegde, Ph.D. “The San Diego region is home to more than 1,200 life sciences companies—we’re excited to embed ourselves in this burgeoning community, deepen our local partnerships and add this high-quality lab space to expand into new projects.”
Foundation Medicine’s labs in Cambridge; Research Triangle Park, North Carolina; and Penzberg, Germany will continue to analyze individual patients’ genomic profiles, using the company’s portfolio of genomic tests, to identify the molecular alterations in a patient's cancer and help physicians match them with relevant personalized treatment approaches, including targeted therapies, immunotherapies and clinical trial options.
In June of 2020, we completed the acquisition of Lexent Bio, Inc., a precision oncology company located in California, developing novel multiomics liquid biopsy platforms to advance cancer care. This acquisition will accelerate our research and development strategy and expand its existing liquid biopsy platforms to advance cancer care for patients. The technology developed by Lexent Bio complements our existing efforts and partnerships aimed at developing advanced diagnostics for physicians, as well as genomically evaluating disease progression and informing treatment decisions at earlier stages of disease. Read more here.
Enter your details and we will notify you when new roles that might be a fit are posted!